Home > Insider Trading > Filing (0000899243-21-005458)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661998	Homology Medicines Inc.	FIXX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1317678	Bradford W Smith	C/O Homology Medicines, Inc. One Patriots Park Bedford MA 01730	Cfo & Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-08	13,500	$0.64	13,500	No	4	M	Direct
Common Stock	Disposition	2021-02-08	13,500	$14.25	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2021-02-05	122,000	$0.00	122,000	$13.78
Common Stock	Restricted Stock Units	Acquisiton	2021-02-05	20,000	$0.00	20,000	$0.00
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2021-02-08	13,500	$0.00	13,500	$0.64

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
122,000	2031-02-05	No	4	A	Direct
20,000		No	4	A	Direct
101,904	2027-04-05	No	4	M	Direct

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020.
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $14.00 to $14.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021.
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.
The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017.